All Stories

  1. Patient-reported preferences in eHealth-based cardiac rehabilitation: A qualitative investigation of behavior change techniques, barriers and facilitators

    Article • Internet Interventions, March 2024, Elsevier

    Dr Boris Schmitz

  2. Living Lab Data of Patient Needs and Expectations for eHealth-Based Cardiac Rehabilitation in Germany and Spain From the TIMELY Study: Cross-Sectional Analysis

    Article • Journal of Medical Internet Research, February 2024, JMIR Publications Inc.

    Dr Boris Schmitz

  3. A behavioral change-based eHealth program for Promoting Regular Physical Activity in Medical Rehabilitation Maintenance: the RehaPlus+ concept (Preprint)

    Article • January 2024, JMIR Publications Inc.

    Dr Boris Schmitz

  4. A Behavioral Change-Based Mobile Intervention for Promoting Regular Physical Activity in Medical Rehabilitation Maintenance of Patients With Coronary Artery Disease: a Controlled Trial (Preprint)

    Article • Journal of Medical Internet Research, January 2024, JMIR Publications Inc.

    Dr Boris Schmitz

  5. Non-coding RNAs in exercise immunology: A systematic review

    Article • Journal of Sport and Health Science, November 2023, Elsevier

    Dr Boris Schmitz

  6. Living Lab Data of Patient Needs and Expectations for eHealth-Based Cardiac Rehabilitation in Germany and Spain From the TIMELY Study: Cross-Sectional Analysis (Preprint)

    Article • October 2023, JMIR Publications Inc.

    Dr Boris Schmitz

  7. Medical Rehabilitation of Patients with Post-COVID-19 Syndrome—A Comparison of Aerobic Interval and Continuous Training

    Article • Journal of Clinical Medicine, October 2023, MDPI AG

    Dr Boris Schmitz

  8. Autonomic dysregulation in long-term patients suffering from Post-COVID-19 Syndrome assessed by heart rate variability

    Article • Scientific Reports, September 2023, Springer Science + Business Media

    Dr Boris Schmitz

  9. Altered tissue oxygenation in patients with post COVID-19 syndrome

    Article • Microvascular Research, July 2023, Elsevier

    Dr Boris Schmitz

  10. eHealth for maintenance cardiovascular rehabilitation: a systematic review and meta-analysis

    Article • European Journal of Preventive Cardiology, May 2023, Oxford University Press (OUP)

    Dr Boris Schmitz

  11. 89. Jahrestagung der Deutsche Gesellschaft für Kardiologie – Herz- und Kreislaufforschung e.V. (German Cardiac Society)

    Article • Clinical Research in Cardiology, April 2023, Springer Science + Business Media

    Dr Boris Schmitz

  12. TIMELY: Providing In-Time and Intelligent Support for Cardiovascular Rehabilitation with ’Patients and Practitioners in the Loop’ Interaction

    Article • March 2023, ACM (Association for Computing Machinery)

    Dr Boris Schmitz

  13. A single session of EMS training induces long-lasting changes in circulating muscle but not cardiovascular miRNA levels - A randomized crossover study

    Article • Journal of Applied Physiology, February 2023, American Physiological Society

    Dr Boris Schmitz

  14. Prognostic and therapeutic potential of microRNAs for fracture healing processes and non‐union fractures: A systematic review

    Article • Clinical and Translational Medicine, January 2023, Wiley

    Dr Boris Schmitz

  15. Improving accessibility of scientific research by artificial intelligence—An example for lay abstract generation

    Article • Digital Health, January 2023, SAGE Publications

    Dr Boris Schmitz

  16. Corrigendum: Health benefits of probiotics in sport and exercise—Non-existent or a matter of heterogeneity? A systematic review

    Article • Frontiers in Nutrition, October 2022, Frontiers

    Dr Boris Schmitz

  17. Defining patients needs and expectations for eHealth-based cardiac rehabilitation in Germany and Spain: living lab data from the TIMELY study

    Article • European Heart Journal, October 2022, Oxford University Press (OUP)

    Dr Boris Schmitz

  18. Patient-centered cardiac rehabilitation by AI-powered lifestyle intervention – the timely approach

    Article • Atherosclerosis, August 2022, Elsevier

    Dr Boris Schmitz

  19. Patient-centered lifestyle intervention using artificial intelligence methodologies: The TIMELY project for cardiac rehabilitation

    Article • Journal of Psychosomatic Research, June 2022, Elsevier

    Dr Boris Schmitz

  20. Therapeutic Potential of Electromyostimulation (EMS) in Critically Ill Patients—A Systematic Review

    Article • Frontiers in Physiology, May 2022, Frontiers

    Dr Boris Schmitz

  21. Health Benefits of Probiotics in Sport and Exercise - Non-existent or a Matter of Heterogeneity? A Systematic Review

    Article • Frontiers in Nutrition, February 2022, Frontiers

    Dr Boris Schmitz

  22. Regulation of antiatherogenic mir-126 by physical exercise

    Article • AJP Heart and Circulatory Physiology, October 2021, American Physiological Society

    Dr Boris Schmitz

  23. Longitudinal choriocapillaris changes in the presence of reticular pseudodrusen

    Article • Scientific Reports, September 2021, Springer Science + Business Media

    Dr Boris Schmitz

  24. Paracentral acute middle maculopathy following high-intensity interval training

    Article • Canadian Journal of Ophthalmology, August 2021, Elsevier

    Dr Boris Schmitz

  25. Four weeks of electromyostimulation improves muscle function and strength in sarcopenic patients: a three‐arm parallel randomized trial

    Article • Journal of Cachexia Sarcopenia and Muscle, June 2021, Wiley

    Dr Boris Schmitz

  26. Sex-specific differences and long-term outcome of patients with coronary artery disease and chronic kidney disease: the Coronary Artery Disease and Renal Failure (CAD-REF) Registry

    Article • Clinical Research in Cardiology, May 2021, Springer Science + Business Media

    Dr Boris Schmitz

  27. Differential effects of high-intensity interval training (HIIT) on choriocapillaris perfusion in healthy adults and patients with type 1 diabetes mellitus (T1DM)

    Article • Microvascular Research, May 2021, Elsevier

    Dr Boris Schmitz

  28. Effect of high-intensity interval training in patients with type 1 diabetes on physical fitness and retinal microvascular perfusion determined by optical coherence tomography angiography

    Article • Microvascular Research, November 2020, Elsevier

    Dr Boris Schmitz

  29. Four weeks of high-intensity interval training (HIIT) improve the cardiometabolic risk profile of overweight patients with type 1 diabetes mellitus (T1DM)

    Article • European Journal of Sport Science, August 2020, Taylor & Francis

    Dr Boris Schmitz

  30. Yo-Yo Intermittent Recovery Level 1 Test for Estimation of Peak Oxygen Uptake: Use Without Restriction?

    Article • Research Quarterly for Exercise and Sport, January 2020, Taylor & Francis

    Dr Boris Schmitz

  31. Sex Differences in High-Intensity Interval Training–Are HIIT Protocols Interchangeable Between Females and Males?

    Article • Frontiers in Physiology, January 2020, Frontiers

    Dr Boris Schmitz

  32. Progressive high-intensity interval training (HIIT) is not superior to unmodified non-progressive HIIT in an uncontrolled setting

    Article • The Journal of Sports Medicine and Physical Fitness, January 2020, Edizioni Minerva Medica

    Dr Boris Schmitz

  33. Correlation analysis of physical fitness and retinal microvasculature by OCT angiography in healthy adults

    Article • PLoS ONE, December 2019, PLOS

    Dr Boris Schmitz

  34. Soluble adenylyl cyclase (sAC) regulates calcium signaling in the vascular endothelium

    Article • The FASEB Journal, December 2019, Federation of American Societies For Experimental Biology (FASEB)

    Dr Boris Schmitz

  35. Neutralising anti‐drug antibodies in Fabry disease can inhibit endothelial enzyme uptake and activity

    Article • Journal of Inherited Metabolic Disease, November 2019, Wiley

    Dr Boris Schmitz

  36. Normative Yo-Yo Intermittent Recovery Level 1 and Yo-Yo Intermittent Endurance Level 1 test values of boys aged 9–16 years

    Article • Journal of Science and Medicine in Sport, September 2019, Elsevier

    Dr Boris Schmitz

  37. A three-step approach identifies novel shear stress-sensitive endothelial microRNAs involved in vasculoprotective effects of high-intensity interval training (HIIT)

    Article • Oncotarget, June 2019, Impact Journals, LLC

    Dr Boris Schmitz

  38. Rare non-coding Desmoglein-2 variant contributes to Arrhythmogenic right ventricular cardiomyopathy

    Article • Journal of Molecular and Cellular Cardiology, June 2019, Elsevier

    Dr Boris Schmitz

  39. Effects of high-intensity interval training on microvascular glycocalyx and associated microRNAs

    Article • AJP Heart and Circulatory Physiology, June 2019, American Physiological Society

    Dr Boris Schmitz

  40. Optische Kohärenztomographie-Angiographie als zukünftiges Diagnostikum in der Sportmedizin?

    Article • Der Ophthalmologe, April 2019, Springer Science + Business Media

    Dr Boris Schmitz

  41. Mutation-specific Fabry disease patient-derived cell model to evaluate the amenability to chaperone therapy

    Article • Journal of Medical Genetics, April 2019, BMJ

    Dr Boris Schmitz

  42. Genome-wide association study suggests impact of chromosome 10 rs139401390 on kidney function in patients with coronary artery disease

    Article • Scientific Reports, February 2019, Springer Science + Business Media

    Dr Boris Schmitz

  43. Dose-Dependent Effect of Enzyme Replacement Therapy on Neutralizing Antidrug Antibody Titers and Clinical Outcome in Patients with Fabry Disease

    Article • Journal of the American Society of Nephrology, November 2018, American Society of Nephrology

    Dr Boris Schmitz

  44. Neutralizing anti-drug antibodies in Fabry disease have no obvious clinical impact?

    Article • Orphanet Journal of Rare Diseases, September 2018, Springer Science + Business Media

    Dr Boris Schmitz

  45. P3819Rare non-coding desmoglein-2 variant contributes to arrhythmogenic right ventricular cardiomyopathy

    Article • European Heart Journal, August 2018, Oxford University Press (OUP)

    Dr Boris Schmitz

  46. Circulating non-coding RNAs as functional markers to monitor and control physical exercise for the prevention of cardiovascular disease

    Article • European Heart Journal, July 2018, Oxford University Press (OUP)

    Dr Boris Schmitz

  47. Commentary: MicroRNA-221/222 Family Counteracts Myocardial Fibrosis in Pressure Overload-Induced Heart Failure

    Article • Frontiers in Cardiovascular Medicine, July 2018, Frontiers

    Dr Boris Schmitz

  48. The Yo-Yo Intermittent Tests: A Systematic Review and Structured Compendium of Test Results

    Article • Frontiers in Physiology, July 2018, Frontiers

    Dr Boris Schmitz

  49. Effects of high-intensity interval training on optic nerve head and macular perfusion using optical coherence tomography angiography in healthy adults

    Article • Atherosclerosis, July 2018, Elsevier

    Dr Boris Schmitz

  50. Characterization of drug-neutralizing antibodies in patients with Fabry disease during infusion

    Article • Journal of Allergy and Clinical Immunology, June 2018, Elsevier

    Dr Boris Schmitz

  51. Circulating microRNAs as functional biomarkers in cardioprotective exercise – The SPORTIVA study

    Article • Sports Orthopaedics and Traumatology, May 2018, Elsevier

    Dr Boris Schmitz

  52. HIIT effects on optic nerve head and macular perfusion by optical coherence tomography angiography

    Article • Sports Orthopaedics and Traumatology, May 2018, Elsevier

    Dr Boris Schmitz

  53. Longer Work/Rest Intervals During High-Intensity Interval Training (HIIT) Lead to Elevated Levels of miR-222 and miR-29c

    Article • Frontiers in Physiology, April 2018, Frontiers

    Dr Boris Schmitz

  54. Comment on “Epigenetics and cardiovascular regenerative medicine in the elderly”

    Article • International Journal of Cardiology, April 2018, Elsevier

    Dr Boris Schmitz

  55. ZFP226 is a novel artificial transcription factor for selective activation of tumor suppressor KIBRA

    Article • Scientific Reports, March 2018, Springer Science + Business Media

    Dr Boris Schmitz

  56. Promoter methylation inhibits expression of tumor suppressor KIBRA in human clear cell renal cell carcinoma

    Article • Clinical Epigenetics, October 2017, Springer Science + Business Media

    Dr Boris Schmitz

  57. Two-year outcome and risk factors for mortality in patients with coronary artery disease and renal failure: The prospective, observational CAD-REF Registry

    Article • International Journal of Cardiology, September 2017, Elsevier

    Dr Boris Schmitz

  58. Yo-Yo IR1 vs. incremental continuous running test for prediction of 3000-m performance

    Article • The Journal of Sports Medicine and Physical Fitness, September 2017, Edizioni Minerva Medica

    Dr Boris Schmitz

  59. Impact of immunosuppressive therapy on therapy-neutralizing antibodies in transplanted patients with Fabry disease

    Article • Journal of Internal Medicine, July 2017, Wiley

    Dr Boris Schmitz

  60. Dose-Response of High-Intensity Training (HIT) on Atheroprotective miRNA-126 Levels

    Article • Frontiers in Physiology, May 2017, Frontiers

    Dr Boris Schmitz

  61. Salt-induced Na+/K+-ATPase-α/β expression involves soluble adenylyl cyclase in endothelial cells

    Article • Pflügers Archiv - European Journal of Physiology, May 2017, Springer Science + Business Media

    Dr Boris Schmitz

  62. Uric acid and essential hypertension

    Article • Journal of Hypertension, November 2016, Wolters Kluwer Health

    Dr Boris Schmitz

  63. Renal function predicts long-term outcome on enzyme replacement therapy in patients with Fabry disease

    Article • Nephrology Dialysis Transplantation, September 2016, Oxford University Press (OUP)

    Dr Boris Schmitz

  64. Physical Exercise in Patients with Fabry Disease – a Pilot Study

    Article • International Journal of Sports Medicine, September 2016, Thieme Publishing Group

    Dr Boris Schmitz

  65. Functional Promoter Variant in Desmocollin-2 Contributes to Arrhythmogenic Right Ventricular Cardiomyopathy

    Article • Circulation Cardiovascular Genetics, August 2016, Wolters Kluwer Health

    Dr Boris Schmitz

  66. Alpha-Galactosidase A p.A143T, a non-Fabry disease-causing variant

    Article • Orphanet Journal of Rare Diseases, May 2016, Springer Science + Business Media

    Dr Boris Schmitz

  67. Baseline Characteristics and Prescription Patterns of Standard Drugs in Patients with Angiographically Determined Coronary Artery Disease and Renal Failure (CAD-REF Registry)

    Article • PLoS ONE, February 2016, PLOS

    Dr Boris Schmitz

  68. Differential response to endothelial epithelial sodium channel inhibition ex vivo correlates with arterial stiffness in humans

    Article • Journal of Hypertension, December 2015, Wolters Kluwer Health

    Dr Boris Schmitz

  69. PP.28.12

    Article • Journal of Hypertension, June 2015, Wolters Kluwer Health

    Dr Boris Schmitz

  70. Serum-Mediated Inhibition of Enzyme Replacement Therapy in Fabry Disease

    Article • Journal of the American Society of Nephrology, April 2015, American Society of Nephrology

    Dr Boris Schmitz

  71. Thromboembolic events in Fabry disease and the impact of factor V Leiden

    Article • Neurology, February 2015, Wolters Kluwer Health

    Dr Boris Schmitz

  72. Aldosterone signaling and soluble adenylyl cyclase—A nexus for the kidney and vascular endothelium

    Article • Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, December 2014, Elsevier

    Dr Boris Schmitz

  73. Salt controls endothelial and vascular phenotype

    Article • Pflügers Archiv - European Journal of Physiology, November 2014, Springer Science + Business Media

    Dr Boris Schmitz

  74. Cryptogenic stroke and small fiber neuropathy of unknown etiology in patients with alpha-galactosidase A-10T genotype

    Article • Orphanet Journal of Rare Diseases, November 2014, Springer Science + Business Media

    Dr Boris Schmitz

  75. Identification of Genetic Markers for Treatment Success in Heart Failure Patients: Insight From Cardiac Resynchronization Therapy

    Article • Circulation Cardiovascular Genetics, September 2014, Wolters Kluwer Health

    Dr Boris Schmitz

  76. Soluble Adenylyl Cyclase in Vascular EndotheliumNovelty and Significance

    Article • Hypertension, January 2014, Wolters Kluwer Health

    Dr Boris Schmitz

  77. Increased monocyte adhesion by endothelial expression of VCAM-1 missense variation in vitro

    Article • Atherosclerosis, October 2013, Elsevier

    Dr Boris Schmitz

  78. Tissue-specific differences in the regulation of KIBRA gene expression involve transcription factor TCF7L2 and a complex alternative promoter system

    Article • Journal of Molecular Medicine, September 2013, Springer Science + Business Media

    Dr Boris Schmitz

  79. Interindividual Transcriptional Regulation of the Human biglycan Gene Involves Three Common Molecular Haplotypes

    Article • Arteriosclerosis Thrombosis and Vascular Biology, April 2013, Wolters Kluwer Health

    Dr Boris Schmitz

  80. Multifocal White Matter Lesions Associated with the D313Y Mutation of the α-Galactosidase A Gene

    Article • PLoS ONE, February 2013, PLOS

    Dr Boris Schmitz

  81. Genetic Variants of the Renin-Angiotensin-Aldosterone System and Reverse Remodeling After Cardiac Resynchronization Therapy

    Article • Journal of Cardiac Failure, October 2012, Elsevier

    Dr Boris Schmitz

  82. Association of left ventricular mass with the AGTR1 A1166C polymorphism

    Article • American Journal of Hypertension, April 2012, Oxford University Press (OUP)

    Dr Boris Schmitz

  83. Are Retinal Microvascular Phenotypes Associated With the 1675G/A Polymorphism in the Angiotensin II Type-2 Receptor Gene?

    Article • American Journal of Hypertension, December 2011, Oxford University Press (OUP)

    Dr Boris Schmitz

  84. Knowledge extraction in a population suffering from heart failure

    Article • November 2010, Institute of Electrical & Electronics Engineers (IEEE)

    Dr. Evanthia E Tripoliti, Dr Boris Schmitz

  85. P422 PROFILING OF BIGLYCAN MOLECULAR PROMOTER HAPLOTYPES

    Article • Atherosclerosis Supplements, June 2010, Elsevier

    Dr Boris Schmitz

  86. Identification and Functional Analyses of Molecular Haplotypes of the Human Osteoprotegerin Gene Promoter

    Article • Arteriosclerosis Thrombosis and Vascular Biology, October 2009, Wolters Kluwer Health

    Dr Boris Schmitz

  87. Molecular investigation of the functional relevance of missense variants of ICAM-1

    Article • Pharmacogenetics and Genomics, November 2008, Wolters Kluwer Health

    Dr Boris Schmitz